PATH | VRL
Menu

Strategic Priorities for Respiratory Syncytial Virus (RSV) Vaccine Development

This review article, published in Vaccine, examines the clinical and epidemiological features of respiratory syncytial virus (RSV), highlights challenges and opportunities for RSV vaccine development, and identifies priority areas for future research and activities to achieve the goal of a safe and effective RSV vaccine.

Author: Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS

Published: 2013

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic Priorities for Respiratory Syncytial Virus (RSV) Vaccine Development. Vaccine. 2013;31(Suppl 2):B209-B215.

Resource types: Peer-reviewed journal

Diseases/vaccines: Respiratory syncytial virus (RSV)

Topics: Disease/vaccine specific information

Regions: Global